Effect of enalapril on diabetic neuropathy; a double blind clinical trial

Vice-chancellor for research - Birjand University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Diabetes type 2 diabetes based on the criteria of american diabetes association (blood sugar after 10 to 12 hours of fasting be more than 126 mg/dl or random BS equal or more than 200 mg/dl) at least for 3 years; Having mild to moderate neuropathy (grade 3 to 5 based on Michigan scoring system); Age between 30 to 80
•Exclusion criteria: history of enalapril consumption during a recent year; Consumers of alcohol; Kidney disease patients; Liver disease patients (moderate to severe); The existence of a wound in the foot; amputation of the lower extremities; Developing gestational diabetes in women; history of hereditary neuropathy or background diseases causing neuropathy; Taking TCA antidepressants drugs; A lack of vitamin B12 (not less than 160mg / dl); A history of renal arteries stenosis; Having one kidney or micro-albuminuria; Sensitivity to ACD inhibitors; Long-term use of non-steroidal inflammatory drugs such as aspirin during the 4 weeks prior to the disease

发起方

Vice-chancellor for research - Birjand University of Medical Sciences